Oyster Point Pharma Inc (OYST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -134,581 | -97,834 | -47,892 | -100,659 | -58,595 |
| Depreciation Amortization | 3,346 | 2,222 | 1,072 | 1,525 | 599 |
| Accounts receivable | -6,528 | -4,262 | 920 | -6,656 | N/A |
| Accounts payable and accrued liabilities | -2,352 | -1,776 | -3,949 | 3,868 | 1,215 |
| Other Working Capital | -12,025 | -8,134 | -10,362 | -3,032 | 1,556 |
| Other Operating Activity | 27,634 | 21,249 | 10,506 | 15,584 | 7,344 |
| Operating Cash Flow | $-124,506 | $-88,535 | $-49,705 | $-89,370 | $-47,881 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -203 | -203 | -85 | -1,485 | -1,250 |
| Investing Cash Flow | $-203 | $-203 | $-85 | $-1,485 | $-1,250 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | N/A | N/A | 95,000 | 40,151 |
| Debt Repayment | -455 | -288 | -207 | N/A | -14 |
| Common Stock Issued | 618 | 617 | 76 | 1,589 | 605 |
| Other Financing Activity | -87 | -87 | -87 | -4,947 | -30 |
| Financing Cash Flow | $76 | $242 | $-218 | $91,642 | $40,712 |
| Beginning Cash Position | 193,433 | 193,433 | 193,433 | 192,646 | 192,646 |
| End Cash Position | 68,800 | 104,937 | 143,425 | 193,433 | 184,227 |
| Net Cash Flow | $-124,633 | $-88,496 | $-50,008 | $787 | $-8,419 |
| Free Cash Flow | |||||
| Operating Cash Flow | -124,506 | -88,535 | -49,705 | -89,370 | -47,881 |
| Capital Expenditure | -203 | -203 | -85 | -1,485 | -1,250 |
| Free Cash Flow | -124,709 | -88,738 | -49,790 | -90,855 | -49,131 |